Advances in the Study of the Inflammatory Association Between Obstructive Sleep Apnea and Coronary Heart Disease
Abstract
highlighting the central role of the inflammatory response. Apnea and hypoxemia during sleep in patients with OSA activate inflammatory
cytokines, such as tumor necrosis factor-alpha and interleukin-6, promoting vascular endothelial damage and plaque formation. Metabolic
dysfunction induced by intermittent hypoxia, particularly insulin resistance and abnormal lipid metabolism, enhances the development of
coronary atherosclerosis. Furthermore, OSA-induced sympathetic hyperactivation elevates the blood pressure and accelerates the heart rate,
further exacerbating the risk of CAD. Therefore, controlling the inflammatory response in patients with OSA is essential for alleviating the
risk of coronary heart disease.
Keywords
Full Text:
PDFReferences
[1] Patel SR. Obstructive Sleep Apnea. Ann Intern Med. 2019 Dec 3;171(11): ITC81-ITC96.
[2] RACANELLI A C, KIKKERS S A, CHOI A M K, et al. Autophagy and inflammation in chronic respiratory disease[J/OL]. Autophagy,
2018, 14(2): 221-232.
[3] GABRYELSKA A, KUNA P, ANTCZAK A, et al. IL-33 Mediated Inflammation in Chronic Respiratory Diseases-Understanding the
Role of the Member of IL-1 Superfamily[J/OL]. Frontiers in Immunology, 2019, 10: 692.
[4] DE LUCA CANTO G, PACHCO-PEREIRA C, AYDINOZ S, et al. Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis[J/OL]. Journal of clinical sleep medicine: JCSM: official publication of the
American Academy of Sleep Medicine, 2015, 11(1): 27-36.
[5] ZHOU Y, XU Z, LIU Z. Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives[J/OL]. Journal
of Translational Medicine, 2023, 21(1): 902.
[6] WANG J, XU J, LIU S, et al. Electroencephalographic Activity and Cognitive Function in Middle-Aged Patients with Obstructive Sleep
Apnea Before and After Continuous Positive Airway Pressure Treatment[J/OL]. Nature and Science of Sleep, 2021, 13: 1495-1506.
[7] GALKINA E, LEY K. Vascular adhesion molecules in atherosclerosis[J/OL]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2007,
27(11): 2292-2301.
[8] HANSSON G K, LIBBY P, TABAS I. Inflammation and plaque vulnerability[J/OL]. Journal of Internal Medicine, 2015, 278(5): 483-493.
[9] KELLY-ARNOLD A, MALDONADO N, LAUDIER D, et al. Revised microcalcification hypothesis for fibrous cap rupture in human
coronary arteries[J/OL]. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110(26): 10741-
10746.
[10] Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, Kanagy NL. Reactive oxygen species contribute to sleep apneainduced hypertension in rats. Am J Physiol Heart Circ Physiol. 2007 Nov;293(5): H2971-6.
[11] Yamauchi M, Tamaki S, Tomoda K, Yoshikawa M, Fukuoka A, Makinodan K, Koyama N, Suzuki T, Kimura H. Evidence for activation
of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath. 2006 Dec;10(4):189-93.
[12] Rats subjected to chronic-intermittent hypoxia have increased density of noradrenergic terminals in the trigeminal sensory and motor
nuclei - PubMed[EB/OL]. [2024-11-07].
[13] DRAGER L F, LI J, REINKE C, et al. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity[J/OL]. Obesity (Silver
Spring, Md.), 2011, 19(11): 2167-2174.
[14] LOUIS M, PUNJABI N M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers[J/OL]. Journal of
Applied Physiology (Bethesda, Md.: 1985), 2009, 106(5): 1538-1544.
[15] NAVAB M, HAMA S Y, HOUGH G P, et al. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or
inactivating oxidized phospholipids[J]. Journal of Lipid Research, 2001, 42(8): 1308-1317.
[16] PAN X, ZHANG X, WU X, et al. Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol
ratio and obstructive sleep apnea: a cross-sectional study from NHANES[J/OL]. Lipids in Health and Disease, 2024, 23(1): 209.
[17] SICA A, MANTOVANI A. Macrophage plasticity and polarization: in vivo veritas[J/OL]. The Journal of Clinical Investigation, 2012,
122(3): 787-795.
[18] LUO M, ZHAO F, CHENG H, et al. Macrophage polarization: an important role in inflammatory diseases[J/OL]. Frontiers in Immunology, 2024, 15: 1352946.
[19] LV R, BAO Q, LI Y. Regulation of M1?type and M2?type macrophage polarization in RAW264.7 cells by Galectin?9[J/OL]. Molecular
Medicine Reports, 2017, 16(6): 9111-9119.
[20] OUYANG W, OGARRA A. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation[J/OL]. Immunity,
2019, 50(4): 871-891.
[21] LIU L, STOKES J V, TAN W, et al. An optimized flow cytometry panel for classifying macrophage polarization[J/OL]. Journal of Immunological Methods, 2022, 511: 113378.
[22] RICHERT I, BERCHARD P, ABBES L, et al. A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune
Response and Reprogramming M2 Macrophages to M1 Macrophages[J/OL]. Cancers, 2023, 15(18): 4635.
DOI: http://dx.doi.org/10.70711/pmr.v2i3.5474
Refbacks
- There are currently no refbacks.